 Michael Bozzella
Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytomegalovirus Retinitis | 1 | 2022 | 22 | 0.730 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2022 | 130 | 0.690 |
Why?
| | Epiglottitis | 1 | 2020 | 4 | 0.630 |
Why?
| | Anti-Bacterial Agents | 2 | 2021 | 1928 | 0.590 |
Why?
| | Vaping | 1 | 2020 | 66 | 0.570 |
Why?
| | Pamphlets | 1 | 2018 | 26 | 0.560 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2020 | 108 | 0.540 |
Why?
| | Infection Control | 1 | 2019 | 174 | 0.530 |
Why?
| | Drug Resistance, Bacterial | 1 | 2018 | 205 | 0.510 |
Why?
| | Cross Infection | 1 | 2019 | 263 | 0.490 |
Why?
| | Antimicrobial Stewardship | 1 | 2018 | 129 | 0.480 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 248 | 0.470 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2019 | 287 | 0.470 |
Why?
| | Staphylococcal Infections | 1 | 2019 | 388 | 0.440 |
Why?
| | Ambulatory Care | 1 | 2018 | 607 | 0.400 |
Why?
| | Microbiota | 1 | 2021 | 782 | 0.400 |
Why?
| | Cystic Fibrosis | 1 | 2021 | 1166 | 0.340 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1360 | 0.300 |
Why?
| | Lung | 1 | 2021 | 4089 | 0.270 |
Why?
| | Ganciclovir | 1 | 2022 | 53 | 0.190 |
Why?
| | Anaerobiosis | 1 | 2021 | 66 | 0.170 |
Why?
| | Cytomegalovirus | 1 | 2022 | 168 | 0.170 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2022 | 95 | 0.170 |
Why?
| | Hoarseness | 1 | 2020 | 4 | 0.160 |
Why?
| | Sputum | 1 | 2021 | 308 | 0.150 |
Why?
| | Respiratory Function Tests | 1 | 2021 | 541 | 0.150 |
Why?
| | District of Columbia | 1 | 2019 | 37 | 0.150 |
Why?
| | Chlorhexidine | 1 | 2019 | 23 | 0.150 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2021 | 564 | 0.150 |
Why?
| | Laryngoscopy | 1 | 2020 | 119 | 0.140 |
Why?
| | Deglutition Disorders | 1 | 2020 | 149 | 0.140 |
Why?
| | Adolescent | 3 | 2022 | 22409 | 0.130 |
Why?
| | Longevity | 2 | 2009 | 175 | 0.130 |
Why?
| | Recombination, Genetic | 2 | 2008 | 205 | 0.130 |
Why?
| | Child | 3 | 2022 | 22600 | 0.120 |
Why?
| | Antiviral Agents | 1 | 2022 | 765 | 0.120 |
Why?
| | Health Services Research | 1 | 2018 | 392 | 0.120 |
Why?
| | Humans | 9 | 2022 | 144667 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2942 | 0.100 |
Why?
| | Fibroblasts | 2 | 2009 | 1019 | 0.100 |
Why?
| | Patient Education as Topic | 1 | 2018 | 771 | 0.100 |
Why?
| | United States | 2 | 2022 | 16018 | 0.090 |
Why?
| | Mole Rats | 1 | 2009 | 4 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2018 | 1406 | 0.080 |
Why?
| | Prospective Studies | 1 | 2021 | 7994 | 0.070 |
Why?
| | Rodentia | 1 | 2008 | 62 | 0.070 |
Why?
| | Genes, Tumor Suppressor | 1 | 2008 | 85 | 0.070 |
Why?
| | Infant | 1 | 2022 | 10023 | 0.070 |
Why?
| | Body Size | 1 | 2008 | 94 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2019 | 6399 | 0.060 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 337 | 0.060 |
Why?
| | DNA Repair | 1 | 2008 | 256 | 0.060 |
Why?
| | Cell Cycle | 1 | 2008 | 595 | 0.060 |
Why?
| | Young Adult | 1 | 2021 | 14122 | 0.050 |
Why?
| | Male | 2 | 2022 | 72431 | 0.050 |
Why?
| | Biological Evolution | 1 | 2008 | 488 | 0.050 |
Why?
| | Female | 2 | 2021 | 78304 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2019 | 17149 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4539 | 0.040 |
Why?
| | DNA Breaks, Double-Stranded | 2 | 2008 | 56 | 0.030 |
Why?
| | Genes, Reporter | 2 | 2008 | 276 | 0.030 |
Why?
| | Neoplasms | 1 | 2009 | 2873 | 0.030 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 2009 | 15 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 64 | 0.020 |
Why?
| | Retinoblastoma Protein | 1 | 2009 | 61 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2009 | 72 | 0.020 |
Why?
| | Rats, Inbred BN | 1 | 2008 | 54 | 0.020 |
Why?
| | Chromosomes, Human | 1 | 2008 | 41 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 254 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2008 | 160 | 0.020 |
Why?
| | Cricetinae | 1 | 2008 | 296 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2008 | 268 | 0.020 |
Why?
| | Cell Communication | 1 | 2009 | 325 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2008 | 223 | 0.010 |
Why?
| | Telomerase | 1 | 2008 | 249 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2009 | 532 | 0.010 |
Why?
| | Telomere | 1 | 2008 | 290 | 0.010 |
Why?
| | Cell Line | 1 | 2008 | 2821 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2009 | 2489 | 0.010 |
Why?
| | Mice | 2 | 2009 | 18261 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2008 | 4110 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1811 | 0.010 |
Why?
| | Rats | 1 | 2008 | 5570 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2008 | 5967 | 0.010 |
Why?
| | Animals | 2 | 2009 | 37948 | 0.010 |
Why?
|
|
Bozzella's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|